Varivax vaccine with diluents
Ended Awarded
- Contract number
- SPE2DB25FQUZT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,106
Award facts
- Contract value 100% obligated
- $2,106.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on July 29, 2025, with a ceiling value of $2,106.02 and an ultimate completion date of August 19, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle that extends through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The Varivax delivery order supports the Defense Health Agency and broader military medical supply chain requirements. The parent SPE2DX contract enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, encompassing specialty medications, vaccines, and related medical commodities. This delivery order aligns with DLA's pharmaceutical procurement strategy and AmerisourceBergen's established role as a preferred vendor for federal vaccine and immunization product distribution.
Quick answers
Who was awarded contract SPE2DB25FQUZT?
SPE2DB25FQUZT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FQUZT worth?
The government has obligated $2,106 on SPE2DB25FQUZT.
Is contract SPE2DB25FQUZT an order under another contract?
Yes. SPE2DB25FQUZT is a delivery order under SPE2DB25D3001, an indefinite delivery contract.
Was contract SPE2DB25FQUZT competed?
The extent of competition for SPE2DB25FQUZT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award